May 24, 2018

Posted June 4, 2018

Pharmaceutical giant Pfizer agreed to pay $23.85 million and enter in to a corporate integrity agreement to resolve claims under the False Claims Act that it induced Medicare patients to use three Pfizer drugs, Sutent, Ilyta, and Tikosyn, by unlawfully covering patients copays in violation of the AKS; in doing so, Pfizer increased its profits and masked the effect of drug price increases. DOJ